Dyne Therapeutics (DYN) DMA 50 (2020 - 2026)

Dyne Therapeutics (DYN) DMA 50 (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 50
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	4.18
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	155.63
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	4.99
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	25.01
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	7.37
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	4.08
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	4.85
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	436.70
9	Abivax	94.37 Bn	94.37 Bn	-	116.57
10	Dyne Therapeutics	2.78 Bn	2.78 Bn	-	18.22

Download Data